Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Quebec green lights third dose of COVID-19 vaccine for 12 to 17 age group

Quebec green lights third dose of COVID-19 vaccine for 12 to 17 age group

Global News
Friday, February 18, 2022 02:40:43 PM UTC

Appointments can be made starting Saturday on the government's Clic-santé website.

Quebecers aged 12 to 17 will be able to get a third dose of the COVID-19 vaccine starting this weekend.

The Health Ministry announced the decision Friday based on new advice from the province’s immunization committee.

“Note that the booster dose should be administered three months or more after the last dose of vaccine received against COVID-19,” the ministry said in a statement.

The committee recommends teenagers who are at higher risk of complications from the virus get the third dose. It will also be made available to anyone older than 12 if they wish to get a booster shot.

Quebec’s Health Ministry says studies about vaccine efficacy in teenagers “show a decrease in protection against infection over time.”

“Like the rest of the population, a booster shot offers a greater vaccine protection against the Omicron variant,” Health Minister Christian Dubé wrote on Twitter.

The committee will also stand by its current recommendation to use the Pfizer vaccine among teenagers, “due to a slightly lower risk of developing complications, such as myocarditis, after vaccination.”

Appointments can be made starting Saturday on the government’s Clic-santé website.

Read full story on Global News
Share this story on:-
More Related News
Conservation officers no longer ‘actively’ looking for grizzly bears in Bella Coola attack

Officers had recently captured four grizzly bears, but forensic results came back to confirm that none of the bears, an adult female and three young, were linked to the attack.

‘Patients get relief’: Researchers recommending nerve blockers to treat migraines

The research recommends occipital nerve blocks should be offered in emergency rooms to treat acute migraine attacks. 

U.S. advisory panel rolls back universal hepatitis B vaccine recommendation

A federal vaccine advisory committee voted on Friday to end the longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.

Alberta mother prepares to welcome ‘miracle’ quadruplets

Darlene Hensch, who once struggled with unexplained infertility, is now expecting quadruplets and preparing for a high-risk delivery and life-changing journey.

Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks

Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.

A ring with an extra carrot ends decades-long mystery for Alberta couple

They've been married for 55 years, but for most of that time, something has been missing from Janet and Robert Cockwill's life, until their grandson made a remarkable discovery.

Liberals are being ‘dishonest’ about future of pharmacare, NDP says

NDP interim leader Don Davies said the government's response to a commissioned report on the program was 'shockingly dismissive,' and the health minister has not committed to act.

Ontario government routinely ignoring environmental consultations, AG finds

The Ford government is routinely making decisions before environmental consultations have concluded and under-resourcing public education about those consultations, the AG found.

Vacancies for nurses, support workers tripled since 2016, StatCan finds

From 2016 to 2024, the vacancy rate for health-related occupations nearly tripled, increasing from 2.1 per cent to 5.8 per cent, the report said.

Alberta’s Smith vows to keep up fight against Ottawa despite pipeline pact

The milestone deal with Ottawa signed earlier this week clears regulatory hurdles for a potential pipeline from Alberta to the West Coast. 

‘Frustrating’: Veterinarians urge regulatory changes as medicine shortages mount

Canadian veterinarians are sounding the alarm about their loss of access to about 40 per cent of medications they once were able to use and they are blaming Health Canada.

© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us